HIF1A and COVID-19: The hamster model of COVID-19 exhibits a mild to moderate form of the disease [18,19,20,21], however, it does replicate features of lung pathology in human patients including the activation of inflammatory cytokines, elevated mitochondrial ROS, hypoxia induced HIF-1α upregulation, accumulation of thrombosis-related proteins in the blood coagulation pathway, and signs of hemolysis.